SEC Filing Details

Document Details

Form
Filing Date
February 3, 2023
Document Date
January 25, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Jasper Therapeutics, Inc
Issuer
JASPER THERAPEUTICS, INC.
Filer
VELAN CAPITAL INVESTMENT MANAGEMENT LP
Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.